The company has 2.50 in cash even if they cease business operations
Under the capital available to the company today, it would not be able to conduct both the additional efficacy study and the additional safety exposures, Polymeropoulos said.
The CEO said Vanda will have to examine a number of options, including potential partnerships and assets to divest, but it will first establish further clarity with the FDA regarding the non-approvable letter.
Any hopes of finding a partner here? Situation sounds pretty dire.
They'll burn about half of that amount if they want to go back and do two more years of trails. Est. losses this year $3.33, 2.20 next year.
They gonna fold up the tent and dispurse to shareholders or keep on keeping on with the sleeping drugs (one to help sleep, one to help in sleepyness)???
This is a nice story to buy deep value and play it out. This thing really got killed of late. Naturally, it would not hold attraction if everything was honky Dorry!
You got minerals briggy!
[Edited by - Nalod on 29-07-2008 11:51 AM]
Briggy,
What is the catalyst for increasing revenue? Sounds like the big drug they were looking for is at least two years out and the other two are minor in comparison.
I see the break up value as you mentioned, and that does not include anything else.
What is the Skinny?
Nice trade so far. Earnings out in a few days.
What is bang?
Its up to a $. Should I get in on this tomorrow morning or will it stay where it is?
Posted by Nalod:
Nice trade so far. Earnings out in a few days.
What is bang?
bang is .84 to 1.07 and out
Bang=explosion or bank it
